The report provides a detailed analysis essential for establishing an Isosorbide Mononitrate production plant. It encompasses all critical aspects necessary for Isosorbide Mononitrate production, including the cost of Isosorbide Mononitrate production, Isosorbide Mononitrate plant cost, Isosorbide Mononitrate production costs, and the overall Isosorbide Mononitrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Isosorbide Mononitrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Isosorbide mononitrate is a prescription medication primarily used in the pharmaceutical industry as a long-acting nitrate drug for the prevention and treatment of angina pectoris caused by coronary artery disease. It works by dilating blood vessels, reducing the workload on the heart, and improving oxygen supply to the heart muscles. It is also used to manage congestive heart failure and hypertensive conditions. Isosorbide derivatives have broader applications as biodegradable surfactants, detergents, emulsifiers, and plasticisers, but the mononitrate form is mainly valued for its cardiovascular therapeutic effects.
The market for isosorbide mononitrate is primarily driven by the global rise in cases of cardiovascular diseases such as angina pectoris and congestive heart failure, mainly among ageing populations. Rising geriatric demographics contribute significantly to demand growth. Expanding healthcare infrastructure, especially in developing regions like Asia-Pacific (China and India), and higher healthcare expenditure in developed markets such as North America and Europe, also fuel market expansion.
Additionally, advancements in drug delivery systems, a focus on bioequivalence for generic formulations, and the development of combination therapies enhance market growth. Emerging trends include improved patient adherence strategies and the adoption of telemedicine for better management of cardiovascular diseases. Industrial isosorbide mononitrate procurement is affected by regulatory compliance and approvals from health authorities, which can cause delays or require adaptations in sourcing. Market demand fluctuations driven by cardiovascular disease prevalence and healthcare policies also influence procurement volume and frequency.
Raw Material for Isosorbide Mononitrate Production
According to the Isosorbide Mononitrate production plant project report, the various raw materials for Isosorbide Mononitrate production include sorbitol- nitric acid.
Production Process of Isosorbide Mononitrate
The extensive Isosorbide Mononitrate production cost report consists of the following major industrial production process:
- Production via chemical synthesis: The production process for isosorbide mononitrate, a derivative of isosorbide, involves nitration of sorbitol with nitric acid. The reaction takes place in the presence of acetic anhydride and acetic acid, followed by crystallisation, filtration, and purification.
Properties of Isosorbide Mononitrate
Isosorbide mononitrate is a white to off-white crystalline solid with the molecular formula C6H9NO6 and a molecular weight of 191.14 g/mol. It has a melting point in the range of 88-93 degree Celsius and an estimated boiling point of 327 degree Celsius. The compound is freely soluble in water, acetone, ethanol (96%), and methylene chloride, with solubility varying depending on the diluent concentration. It is characterised by a refractive index of about 1.45 and a density estimated at 1.58 g/cm³. Isosorbide mononitrate is highly flammable and may be toxic if ingested. It is a nitrate ester derivative of isosorbide, acting as a nitric oxide donor and vasodilator, primarily used as an antianginal agent. The substance is stable in air and solution and functions by relaxing vascular smooth muscles to improve blood flow.